Inscopix Inc., a leading neurotechnology company in California that empowers breakthroughs in brain science, announced today that Martin Verhoef has joined the company as Chief Commercial Officer. As a key member of Inscopix’s executive leadership team, Mr. Verhoef will lead all commercial operations, spanning strategy, sales, marketing, business development and customer success.

Inscopix Inc.是加州一家领先的神经技术公司，致力于在脑科学领域取得突破。该公司今天宣布，马丁·费尔霍夫(Martin Verhoef)已加入公司担任首席商务官。作为Inscopix的执行领导团队的关键成员，Verhoef先生将领导所有商业运营，跨越战略、销售、营销、业务发展和客户成功。

Mr. Verhoef brings over thirty years of leadership experience in the life science tools and technology industry. He joins Inscopix from the Danaher corporation, where he served as VP of Innovation, Danaher Life Science Instruments Group. Prior to that, he led Strategy, Marketing, and R&D at Molecular Devices for six years. Mr. Verhoef has also worked as the CEO of Primera Dx and Executive VP of Ciphergen Biosystems, and in various roles at Hewlett Packard / Agilent.

Verhoef先生在生命科学工具和技术行业拥有超过30年的领导经验。他从丹纳赫公司(Danaher corporation)加入Inscopix，在那里他曾担任丹纳赫生命科学仪器集团(Danaher Life Science Instruments Group)创新副总裁。在此之前，他在Molecular Devices领导策略、营销和研发6年。Verhoef先生也曾担任Primera Dx的首席执行官和Ciphergen Biosystems的执行副总裁，以及Hewlett Packard / Agilent的各种职务。

Dr. Kunal Ghosh, CEO & Founder of Inscopix said, "I am very pleased to welcome Martin Verhoef to the Inscopix team. Martin has a stellar track record in commercializing new platforms for life science discovery and clinical applications, and I have no doubt that his wealth of experience will help propel Inscopix to the next level as we seek expansion in the neuroscience research market and make an impact on human brain health."

Inscopix首席执行官兼创始人Kunal Ghosh博士表示:“我非常高兴地欢迎Martin Verhoef加入Inscopix团队。马丁在商业化新平台有很好的记录生命科学发现和临床应用,我毫不怀疑,他丰富的经验将有助于推动Inscopix更上一层楼,我们寻求扩张在神经科学研究市场和对人类大脑的健康产生影响。”

"I am honored and thrilled to join Inscopix, a company that is pushing the frontiers of neuroscience and preclinical therapeutic development through cutting-edge innovations," said Mr. Verhoef. "I look forward to helping scale Inscopix’s growth and to translate the world class neuroscience already catalyzed by the company’s brain-mapping platform into cutting-edge neurotherapies for brain disorders such as Parkinson’s, Autism, depression, and Alzheimer’s."

Verhoef先生说:“我很荣幸也很激动能加入Inscopix，一家通过尖端创新推动神经科学和临床前治疗发展前沿的公司。”“我期待着帮助扩大Inscopix的增长，并将世界一流的神经科学技术转化为治疗帕金森症、自闭症、抑郁症和阿尔茨海默氏症等脑部疾病的尖端神经疗法。”

Mr. Verhoef received his double bachelor’s degree in Clinical Chemistry (1980) and Analytical Chemistry (1985), both from the Van 't Hoff Institute, Rotterdam, The Netherlands.

Verhoef先生在荷兰鹿特丹Van’t Hoff Institute获得临床化学(1980年)和分析化学(1985年)双学士学位。

About Inscopix, Inc.

关于Inscopix公司。